Randomised clinical trial of intravitreal Avastin vs photodynamic…
January 23rd, 2009
Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results Ursula Schmidt-Erfurth, MD, is an owner of the patent on the use of green porphyrins in neovasculature of the eye under the guidelines of the Wellman Laboratories of Photomedicine, Harvard Medical School, Boston, MA, USA.
Original post by Nature Publishing Group
(click on the author/publication link above to see full post)